![With Novo Nordisk's Wegovy weight-loss drug in short supply, the company's owner agreed to buy contract manufacturer Catalent for $16.5 billion, including…](https://cdn.newsserve.net/ONPglobe256.png)
With Novo Nordisk's Wegovy weight-loss drug in short supply, the company's owner agreed to buy contract manufacturer Catalent for $16.5 billion, including…
Novo Holdings, the parent company of Danish pharma giant Novo Nordisk, agreed to buy New Jersey-based contract manufacturer..